A scholarly update on the previous (2016) guidelines, with an interesting Chapter 9 Gaps in evidence and future perspectives. The guidelines have been extensively reviewed by European and other experts. The authors insist on the only advisory value of their conclusions. Understandably, there is no mention of venous ECMO.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Venous Disease
January 14, 2022
August 14, 2021
Interesting multi-center RCT that paves the way for potential paradigm shifts in antithrombotic modulation. The abcence of symptomatic pulmonary embolism warrants further investigation...
January 16, 2021
A recent European consensus paper. Relatively easily read, and favouring meta-analyses over randomised trials. The bulk of the manuscript is of interest to all healthcare providers. The chapters 2.8.1 and 3.1.2 are of additional relevance to the ctsnet readership, as they summarise guidance on interventions.
July 14, 2020
A small histopathological study of SARS and influenza autopsies compared to rejected for transplantation lungs. There is some speculation on the popular procoagulopathic nature of the panvirus, based on expression of angiotensin converting enzyme 2.There might be a collateral stimulus for lung preservation in organ retrieval.
May 6, 2020
Use of anatomic abbreviations instead of numbers seems pro-intuitive ...
May 14, 2018
Thomas and colleagues performed a retrospective analysis of patient information from the National Surgical Quality Improvement Program database to identify risk factors for postdischarge venous thromboembolism (VTE) following lung resection.
June 11, 2016
The authors summarize findings in a single institution retrospective review of patients undergoing pre-discharge VTE screening after pneumonectomy for NSCLC and compare outcomes to an historic series of patients who did not have screening. Rates of VTE in the screened group were 8.9% at discharge, an additional 3.4% within 30 days postop, and 5.4% &
May 8, 2016
The entire issue is dedicated to thrombosis and makes a compulsory read for cardiovascular and thoracic hospitalists. Of patricular relevance to the thoracic surgeon are the translational articles on system analysis (page 1348) and the table on oral anticoagulants on page 1410.
October 7, 2013
This study of 389 pts receiving a continuous flow LVAD evaluated the risk of thromoembolic (TE)complications associated with preop AF. TE occured in 25% of pts; freedom from TE at 2 years was 46% in those with AF and 72% in those without AF (p<0.001). AF did not affect late survival.